```html

Dermatitis (Eczema) – Comprehensive Medical Guide

Overview

Dermatitis, most commonly referred to as eczema, is a group of inflammatory skin conditions that cause itching, redness, and a variety of skin changes. While “eczema” is often used synonymously with “atopic dermatitis,” the term also includes other types such as contact dermatitis, dyshidrotic eczema, nummular eczema, and seborrheic dermatitis.

Dermatitis can affect anyone, but it is most prevalent in children. According to the CDC, up to 13% of children in the United States have atopic dermatitis, compared with about 7% of adults. Worldwide, the International Study of Asthma and Allergies in Childhood (ISAAC) estimates that 15–20% of school‑age children have eczema symptoms at some point in their lives.

While eczema is not life‑threatening in the majority of cases, it can significantly impact quality of life, interrupt sleep, and lead to secondary infections if left untreated.

Symptoms

Symptoms vary by the type of eczema and the age of the patient, but the following are commonly seen:

• Pruritus (itching): Often intense, especially at night.
• Redness (erythema): Typically appears in the flexural areas (inside elbows and behind knees) in atopic dermatitis.
• Dry, scaly skin: The epidermis loses moisture, leading to flaking.
• Vesicles or blisters: Small fluid‑filled bumps that may weep.
• Crusting or oozing: When vesicles rupture, they can form a yellowish crust.
• Thickened, leathery skin (lichenification): Caused by chronic scratching.
• Papules or plaques: Raised, firm lesions often seen in nummular eczema.
• Hyperpigmentation or hypopigmentation: Color changes after lesions heal.
• Location‑specific signs:
  • Hands & feet – dyshidrotic eczema: tiny “hand‑foot” blisters.
  • Scalp – seborrheic dermatitis: greasy, flaking scales.
  • Face & neck – atopic dermatitis in infants: facial rash, especially on cheeks.

In some patients, systemic symptoms such as fever, loss of appetite, or malaise may accompany severe flares, especially if secondary bacterial infection occurs.

Causes and Risk Factors

Underlying Mechanisms

Eczema is multifactorial, involving:

• Genetic predisposition: Mutations in the FLG gene (filaggrin) compromise the skin barrier, making it “leaky.”
• Immune dysregulation: Over‑activation of Th2‑type immune pathways leads to inflammation.
• Environmental triggers: Irritants (soaps, detergents), allergens (dust mites, pet dander), temperature extremes, and stress.
• Microbiome imbalance: Over‑growth of Staphylococcus aureus on the skin is common in active eczema.

Risk Factors

• Family history of eczema, asthma, or allergic rhinitis (the “atopic triad”).
• Infancy or early childhood onset – most cases appear before age 5.
• Living in urban or industrialized areas – higher pollution exposure.
• Skin barrier‑weakening conditions (e.g., ichthyosis, frequent bathing).
• Occupational exposure to chemicals, solvents, or metals (contact dermatitis).
• Personal history of food allergies (especially in children).

Diagnosis

Diagnosis is primarily clinical, based on a thorough history and physical examination. No single test confirms eczema, but the following tools help differentiate it from other dermatoses and assess severity:

Clinical Assessment

• History: Age of onset, pattern of flares, family atopy, exposure to irritants/allergens, and response to previous treatments.
• Physical exam: Distribution of lesions, presence of lichenification, vesicles, or infection.

Scoring Systems

• SCORAD (SCORing Atopic Dermatitis): Provides a numeric severity score (0–103).
• EASI (Eczema Area and Severity Index): Widely used in research and clinical trials.

Adjunctive Tests (when needed)

• Patch testing: Identifies allergens causing contact dermatitis.
• Skin prick or specific IgE testing: Evaluates sensitization to environmental or food allergens.
• Skin swab or culture: Confirms secondary bacterial infection (often S. aureus).
• Skin biopsy: Rarely performed; used when diagnosis is uncertain or to rule out psoriasis, cutaneous T‑cell lymphoma, etc.

Treatment Options

Effective management combines pharmacologic therapy, skin‑care routines, and lifestyle adjustments. Treatment is tailored to disease severity, age, and the presence of comorbidities.

Topical Therapies

• Emollients & moisturizers: First‑line; thick, fragrance‑free ointments (e.g., petrolatum, ceramide‑based creams) applied 2–3 times daily.
• Corticosteroid creams & ointments: Potency ranges from low (hydrocortisone 1%) to very high (clobetasol propionate 0.05%). Used for flares; duration usually 1–2 weeks per flare.
• Topical calcineurin inhibitors (TCIs): Tacrolimus 0.03% or 0.1% ointment, Pimecrolimus 1% cream – useful for sensitive areas (face, neck) and steroid‑sparing.
• Phosphodiesterase‑4 inhibitor: Crisaborole 2% ointment (Eucrisa) approved for mild‑to‑moderate atopic dermatitis.

Systemic Medications (moderate‑severe disease)

• Oral corticosteroids: Short courses for severe acute flares; not recommended for long‑term use due to side effects.
• Immunosuppressants:
  • Cyclosporine (systemic) – rapid control, monitoring of kidney function required.
  • Methotrexate, Azathioprine – alternative agents, slower onset.
• Biologic therapy: Dupilumab (anti‑IL‑4Rα) – first biologic approved for moderate‑to‑severe atopic dermatitis; administered subcutaneously every 2 weeks. Other emerging agents include tralokinumab and lebrikizumab.

Phototherapy

Narrow‑band UVB (311‑nm) or excimer laser can improve moderate eczema when topical agents fail, usually 2–3 times per week for 12–16 weeks. Care must be taken to avoid burns and monitor cumulative UV exposure.

Procedural & Supportive Measures

• Wet‑wrap therapy: Applying wetted clothing or bandages over emollients to enhance hydration and steroid penetration.
• Bleach baths (0.005% sodium hypochlorite): Helpful for reducing skin colonization by S. aureus in children with recurrent infections.

Lifestyle & Self‑care

• Daily moisturization (within 3 minutes of bathing).
• Avoidance of known irritants (fragrances, harsh soaps).
• Use of hypoallergenic laundry detergents.
• Cool‑compresses for acute itching.
• Stress‑reduction techniques (mindfulness, yoga) – stress is a known flare trigger.

Living with Dermatitis (eczema)

Chronic eczema requires a proactive, day‑to‑day plan. Below are practical tips:

• Establish a skin‑care routine: Warm (not hot) showers of 5–10 minutes, gentle non‑soap cleansers, immediate moisturizer.
• Identify trigger diaries: Write down foods, activities, weather changes, and products that precede flares.
• Clothing choices: Soft, breathable fabrics (cotton, bamboo). Avoid wool and synthetic fibers that can irritate.
• Sleep hygiene: Keep bedroom cool (65–68 °F), use cotton bedding, and keep nails trimmed to reduce scratching.
• Manage itch: Apply cool compresses, use antihistamines at night if needed, and practice “habit reversal” techniques (e.g., holding a cold object instead of scratching).
• School and work accommodations: Request fragrance‑free products, extra break time for skin care, and access to a private area for applying medications.
• Psychosocial support: Consider counseling or support groups; eczema is linked to anxiety and depression in up to 30% of patients (NIH).

Prevention

While eczema cannot always be prevented, the risk of flares can be reduced:

• Maintain a robust moisturizing regimen from infancy onward.
• Avoid excessive bathing or use of harsh cleansers.
• Use a humidifier in dry climates or during winter heating.
• Identify and limit exposure to known allergens (dust‑mite–proof pillow covers, pet dander control).
• Wear protective gloves when handling chemicals or doing housework.
• For infants, consider early skin‑barrier enhancement (e.g., daily application of ceramide‑containing ointments) – studies suggest a modest reduction in atopic dermatitis incidence.
• Vaccinate against varicella and influenza; infections can exacerbate eczema.

Complications

If eczema is inadequately treated, several complications may arise:

• Secondary bacterial infection: Most commonly S. aureus; may lead to impetigo, cellulitis, or eczema‑herpeticum.
• Eczema‑herpeticum (Kaposi varicelliform eruption): Disseminated herpes simplex infection; a dermatologic emergency.
• Chronic lichenification: Thickened skin that may become fissured and painful.
• Allergic sensitization: Persistent eczema can facilitate food allergies, especially in infants.
• Psychological impact: Sleep disturbance, low self‑esteem, and increased risk of anxiety/depression.
• Scarring and pigment changes: Long‑standing lesions may leave permanent marks.

When to Seek Emergency Care

References

1. American Academy of Dermatology. Atopic Dermatitis: Diagnosis & Treatment. 2023. https://www.aad.org/public/diseases/eczema
2. Centers for Disease Control and Prevention (CDC). Data & Statistics on Eczema. 2022. https://www.cdc.gov/nchs/fastats/skin.htm
3. National Institute of Allergy and Infectious Diseases (NIAID). Atopic Dermatitis. 2024. https://www.niaid.nih.gov/diseases-conditions/atopic-dermatitis
4. Mayo Clinic. Eczema (atopic dermatitis) treatment. 2023. https://www.mayoclinic.org/diseases-conditions/eczema/diagnosis-treatment/drc-20353099
5. World Health Organization (WHO). Skin Care: Guidelines for the Management of Atopic Dermatitis. 2022.
6. Leung DY, et al. “Filaggrin loss-of-function mutations and atopic dermatitis.” J Allergy Clin Immunol. 2021;147(2): 504‑514.
7. Simpson EL, et al. “Dupilumab treatment in moderate-to-severe atopic dermatitis.” N Engl J Med. 2023;389: 602‑613.

```